Trials / Sponsors / 4D Molecular Therapeutics
4D Molecular Therapeutics
Industry · 10 registered clinical trials — 4 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Rel Neovascular Age-Related Macular Degeneration (nAMD) | Phase 3 | 2025-07-22 |
| Active Not Recruiting | 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration Macular Neovascularization Secondary to Age-Related Macular Degeneration | Phase 3 | 2025-03-03 |
| Active Not Recruiting | 4D-150 in Patients With Diabetic Macular Edema Diabetic Macular Edema, Diabetic Retinopathy | Phase 2 | 2023-08-09 |
| Recruiting | 4D-310 in Adults With Fabry Disease and Cardiac Involvement Fabry Disease | Phase 1 / Phase 2 | 2022-10-16 |
| Recruiting | 4D-710 in Adult Patients With Cystic Fibrosis Cystic Fibrosis Lung | Phase 2 | 2022-03-29 |
| Recruiting | 4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration Neovascular (Wet) Age-Related Macular Degeneration | Phase 1 / Phase 2 | 2021-12-09 |
| Active Not Recruiting | An Open-label, Phase 1/2 Trial of Gene Therapy 4D-310 in Adults With Fabry Disease Fabry Disease | Phase 1 / Phase 2 | 2020-09-01 |
| Active Not Recruiting | 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) X-Linked Retinitis Pigmentosa | Phase 1 / Phase 2 | 2020-06-09 |
| Active Not Recruiting | Dose Escalation Study of Intravitreal 4D-110 in Patients With Choroideremia Choroideremia | Phase 1 | 2020-06-02 |
| Terminated | "Natural History" Study of Choroideremia Choroideremia | — | 2016-12-01 |